
Trump Signs Executive Order Imposing Tariffs on Patented Drugs
President Donald Trump signed an executive order imposing tariffs of up to 100% on some patented drugs. The tariffs are aimed at pressuring pharmaceutical companies to reach pricing deals with the administration or shift production to the United States. The order was signed on the anniversary of Trump's 'Liberation Day'.

Trump Imposes 100% Drug Tariffs, Demanding US Production and Price Deals
President Trump signed an executive order imposing tariffs of up to 100% on patented drugs, aiming to compel pharmaceutical companies to sign "most favored nation" pricing deals and move manufacturing, including ingredients, to the United States. The order cites national security concerns over drug imports, offering 0% tariffs for compliance but escalating to 100% for non-compliant firms over four years. This strategy seeks to reduce drug costs and boost domestic production.

Trump Cites National Security for Drug Tariffs
President Trump's executive order imposes tariffs of up to 100% on patented drugs, explicitly citing a threatened impairment of national security from pharmaceutical imports and ingredients. The administration presents this economic policy as a necessary measure for national defense, designed to compel pharmaceutical companies into pricing agreements or onshore production in the United States.











